Anthemis Exponential Ventures
30
17M
15
3
0.50
- Areas of investment
Summary
The company was established in Europe in United Kingdom. The main office of represented VC is situated in the London.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Anthemis Exponential Ventures, startups are often financed by SOSV, HAX, Tera Ventures. The meaningful sponsors for the fund in investment in the same round are Anthemis Group, SOSV, RGAx. In the next rounds fund is usually obtained by Tera Ventures, SOSV, HAX.
Considering the real fund results, this VC is 3 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2017. The fund is constantly included in 2-6 investment rounds annually. The usual things for fund are deals in the range of 5 - 10 millions dollars.
We can highlight the next thriving fund investment areas, such as Artificial Intelligence, Information Technology. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Monese, ABAKA Holdings, Feel. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom.
Investments analytics
Analytics
- Total investments
- 30
- Lead investments
- 3
- Follow on index
- 0.50
- Investments by industry
- Medical Device (14)
- Health Care (11)
- Biotechnology (10)
- FinTech (9)
- Health Diagnostics (9) Show 30 more
- Investments by region
-
- United Kingdom (13)
- United States (14)
- Kenya (1)
- Belgium (1)
- United Arab Emirates (1)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Avg. valuation at time of investment
- 60M
- Group Appearance index
- 0.93
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Feel Therapeutics | 18 Dec 2018 | Biotechnology, Health Care, Health Diagnostics, Medical Device, Health Insurance, Psychology | Seed | 1M | United States, California, San Francisco |
| Intelecy | 04 Sep 2019 | Information Technology, Machine Learning, Industrial | Seed | 0 | Norway, Oslo |
| YuLife | 28 May 2019 | Wellness, Insurance, Gamification, Life Insurance | Early Stage Venture | 13M | England, London, United Kingdom |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.